CN Stock MarketDetailed Quotes

688076 Jiangsu Sinopep-Allsino Biopharmaceutical

Watchlist
  • 53.81
  • -0.35-0.65%
Market Closed Sep 13 15:00 CST
11.83BMarket Cap33.95P/E (TTM)

Jiangsu Sinopep-Allsino Biopharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
107.47%831.5M
71.02%355.82M
58.69%1.03B
85.61%709.47M
49.38%400.78M
54.98%208.06M
1.15%651.29M
-15.03%382.24M
-13.17%268.3M
-19.22%134.25M
Operating revenue
107.47%831.5M
71.02%355.82M
58.69%1.03B
85.61%709.47M
49.38%400.78M
54.98%208.06M
1.15%651.29M
-15.03%382.24M
-13.17%268.3M
-19.22%134.25M
Total operating cost
63.38%552.76M
50.01%268.73M
51.01%827.28M
57.57%576.24M
33.32%338.33M
49.65%179.15M
6.75%547.84M
0.78%365.71M
2.47%253.78M
-0.50%119.71M
Operating cost
59.87%271.76M
27.05%116.48M
45.99%403.4M
57.82%278.91M
33.89%169.99M
49.19%91.68M
-3.00%276.32M
-9.85%176.73M
-6.06%126.96M
-9.22%61.45M
Operating tax surcharges
25.71%4.06M
-3.39%705.18K
-22.15%7.2M
-7.15%4.78M
-29.31%3.23M
30.55%729.96K
76.45%9.25M
99.83%5.14M
123.96%4.57M
35.60%559.16K
Operating expense
-10.06%28.67M
-37.07%11.49M
64.80%57.63M
70.84%45.8M
73.77%31.87M
53.71%18.25M
177.80%34.97M
176.22%26.81M
156.23%18.34M
337.91%11.87M
Administration expense
45.85%130.67M
59.03%70.57M
40.88%222.58M
35.66%153.61M
20.73%89.59M
29.45%44.38M
9.07%157.99M
8.39%113.23M
12.02%74.21M
5.85%34.28M
Financial expense
34.92%5.1M
-20.22%3.25M
7,188.15%11.59M
234.83%7.75M
200.49%3.78M
489.36%4.07M
-106.39%-163.5K
-201.10%-5.75M
-163.63%-3.76M
-138.11%-1.04M
-Interest expense (Financial expense)
97.16%13.88M
87.40%6.35M
73.65%16.09M
81.94%11.06M
118.06%7.04M
218.94%3.39M
51.40%9.26M
14.61%6.08M
-30.37%3.23M
-42.81%1.06M
-Interest Income (Financial expense)
18.13%-3.15M
33.77%-1.26M
27.62%-6.21M
21.75%-5.13M
13.10%-3.85M
22.14%-1.91M
-62.00%-8.58M
-287.85%-6.55M
-481.30%-4.43M
-739.02%-2.45M
Research and development
182.24%112.49M
230.56%66.25M
79.77%124.89M
72.36%85.4M
19.11%39.86M
59.20%20.04M
10.12%69.47M
11.54%49.55M
7.42%33.46M
-12.35%12.59M
Credit Impairment Loss
-2,378.07%-13.07M
-206.30%-3.56M
12.48%-5.24M
-93.01%-5.51M
79.64%-527.58K
471.02%3.35M
-299.73%-5.99M
-952.39%-2.86M
-257.26%-2.59M
1,549.58%586.5K
Asset Impairment Loss
19.65%-10.14M
-4.11%-6.14M
-12.68%-28.89M
1.80%-16.69M
-7.30%-12.62M
-34.19%-5.9M
-62.74%-25.64M
-41.34%-16.99M
-42.69%-11.76M
-366.02%-4.4M
Other net revenue
Fair value change income
-12.99%-3.13M
----
113.11%257.52K
-76.95%-3.39M
-294.12%-2.77M
-308.00%-359.5K
-1,585.31%-1.96M
---1.92M
---703.72K
--172.83K
Invest income
-149.71%-463.05K
-40.10%173.46K
-85.46%2.9M
-89.15%2.15M
-95.20%931.45K
-43.50%289.61K
547.10%19.96M
1,006.69%19.81M
5,224.31%19.41M
72.35%512.57K
Asset deal income
----
----
-99.07%176.42K
-99.50%95.2K
376.01%95.2K
--44.05K
31,919.42%18.89M
--18.89M
--20K
----
Other revenue
5.65%6.98M
17.62%3.27M
-12.05%14.19M
10.66%11.19M
-11.52%6.61M
-28.15%2.78M
38.87%16.14M
23.93%10.12M
42.37%7.47M
142.49%3.87M
Operating profit
378.00%258.91M
177.61%80.82M
51.91%189.67M
177.80%121.07M
105.49%54.16M
90.53%29.11M
-2.70%124.85M
-48.89%43.58M
-56.33%26.36M
-67.35%15.28M
Add:Non operating Income
64.87%385.28K
-58.44%69.73K
-54.11%554.64K
-57.03%442.09K
-46.03%233.69K
-1.82%167.81K
97.71%1.21M
227.73%1.03M
369.46%432.98K
3.19%170.91K
Less:Non operating expense
-64.24%2.33M
-92.37%439.18K
489.03%17.09M
199.31%6.67M
257.19%6.52M
1,005.68%5.75M
-9.12%2.9M
162.49%2.23M
352.51%1.83M
398.20%520.3K
Total profit
436.73%256.96M
241.94%80.45M
40.57%173.13M
170.97%114.85M
91.77%47.88M
57.59%23.53M
-2.05%123.16M
-49.98%42.38M
-58.43%24.97M
-68.13%14.93M
Less:Income tax cost
214.01%25.2M
242.17%15.89M
1,879.38%7.67M
490.92%24.51M
214.35%8.02M
7,467.61%4.64M
-97.71%387.71K
-141.22%-6.27M
-165.51%-7.02M
-100.74%-63.01K
Net profit
481.58%231.77M
241.88%64.56M
34.77%165.45M
85.68%90.34M
24.60%39.85M
25.96%18.89M
12.83%122.77M
-30.02%48.65M
-35.18%31.98M
-60.93%14.99M
Net profit from continuing operation
481.58%231.77M
241.88%64.56M
34.77%165.45M
85.68%90.34M
24.60%39.85M
25.96%18.89M
12.83%122.77M
-30.02%48.65M
-35.18%31.98M
-60.93%14.99M
Less:Minority Profit
330.04%4.6M
17.19%-1.76M
139.72%2.52M
69.76%-1.37M
29.80%-2M
-93.46%-2.13M
3.71%-6.34M
-20.88%-4.54M
-37.20%-2.85M
16.34%-1.1M
Net profit of parent company owners
442.77%227.16M
215.65%66.33M
26.20%162.94M
72.41%91.71M
20.15%41.85M
30.57%21.01M
11.89%129.11M
-27.41%53.19M
-32.25%34.83M
-59.45%16.09M
Earning per share
Basic earning per share
430.00%1.06
210.00%0.31
24.59%0.76
72.00%0.43
25.00%0.2
25.00%0.1
1.67%0.61
-37.50%0.25
-46.67%0.16
-68.00%0.08
Diluted earning per share
405.00%1.01
200.00%0.3
24.59%0.76
72.00%0.43
25.00%0.2
25.00%0.1
1.67%0.61
-37.50%0.25
-46.67%0.16
-68.00%0.08
Other composite income
-24.62M
Other composite income of parent company owners
----
----
---24.62M
----
----
----
----
----
----
----
Total composite income
481.58%231.77M
241.88%64.56M
14.71%140.83M
85.68%90.34M
24.60%39.85M
25.96%18.89M
12.83%122.77M
-30.02%48.65M
-35.18%31.98M
-60.93%14.99M
Total composite income of parent company owners
442.77%227.16M
215.65%66.33M
7.14%138.32M
72.41%91.71M
20.15%41.85M
30.57%21.01M
11.89%129.11M
-27.41%53.19M
-32.25%34.83M
-59.45%16.09M
Total composite income of minority owners
330.04%4.6M
17.19%-1.76M
139.72%2.52M
69.76%-1.37M
29.80%-2M
-93.46%-2.13M
3.71%-6.34M
-20.88%-4.54M
-37.20%-2.85M
16.34%-1.1M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Zhongtianyun Certified Public Accountants (Special General Partnership)
--
--
--
Zhongtianyun Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 107.47%831.5M71.02%355.82M58.69%1.03B85.61%709.47M49.38%400.78M54.98%208.06M1.15%651.29M-15.03%382.24M-13.17%268.3M-19.22%134.25M
Operating revenue 107.47%831.5M71.02%355.82M58.69%1.03B85.61%709.47M49.38%400.78M54.98%208.06M1.15%651.29M-15.03%382.24M-13.17%268.3M-19.22%134.25M
Total operating cost 63.38%552.76M50.01%268.73M51.01%827.28M57.57%576.24M33.32%338.33M49.65%179.15M6.75%547.84M0.78%365.71M2.47%253.78M-0.50%119.71M
Operating cost 59.87%271.76M27.05%116.48M45.99%403.4M57.82%278.91M33.89%169.99M49.19%91.68M-3.00%276.32M-9.85%176.73M-6.06%126.96M-9.22%61.45M
Operating tax surcharges 25.71%4.06M-3.39%705.18K-22.15%7.2M-7.15%4.78M-29.31%3.23M30.55%729.96K76.45%9.25M99.83%5.14M123.96%4.57M35.60%559.16K
Operating expense -10.06%28.67M-37.07%11.49M64.80%57.63M70.84%45.8M73.77%31.87M53.71%18.25M177.80%34.97M176.22%26.81M156.23%18.34M337.91%11.87M
Administration expense 45.85%130.67M59.03%70.57M40.88%222.58M35.66%153.61M20.73%89.59M29.45%44.38M9.07%157.99M8.39%113.23M12.02%74.21M5.85%34.28M
Financial expense 34.92%5.1M-20.22%3.25M7,188.15%11.59M234.83%7.75M200.49%3.78M489.36%4.07M-106.39%-163.5K-201.10%-5.75M-163.63%-3.76M-138.11%-1.04M
-Interest expense (Financial expense) 97.16%13.88M87.40%6.35M73.65%16.09M81.94%11.06M118.06%7.04M218.94%3.39M51.40%9.26M14.61%6.08M-30.37%3.23M-42.81%1.06M
-Interest Income (Financial expense) 18.13%-3.15M33.77%-1.26M27.62%-6.21M21.75%-5.13M13.10%-3.85M22.14%-1.91M-62.00%-8.58M-287.85%-6.55M-481.30%-4.43M-739.02%-2.45M
Research and development 182.24%112.49M230.56%66.25M79.77%124.89M72.36%85.4M19.11%39.86M59.20%20.04M10.12%69.47M11.54%49.55M7.42%33.46M-12.35%12.59M
Credit Impairment Loss -2,378.07%-13.07M-206.30%-3.56M12.48%-5.24M-93.01%-5.51M79.64%-527.58K471.02%3.35M-299.73%-5.99M-952.39%-2.86M-257.26%-2.59M1,549.58%586.5K
Asset Impairment Loss 19.65%-10.14M-4.11%-6.14M-12.68%-28.89M1.80%-16.69M-7.30%-12.62M-34.19%-5.9M-62.74%-25.64M-41.34%-16.99M-42.69%-11.76M-366.02%-4.4M
Other net revenue
Fair value change income -12.99%-3.13M----113.11%257.52K-76.95%-3.39M-294.12%-2.77M-308.00%-359.5K-1,585.31%-1.96M---1.92M---703.72K--172.83K
Invest income -149.71%-463.05K-40.10%173.46K-85.46%2.9M-89.15%2.15M-95.20%931.45K-43.50%289.61K547.10%19.96M1,006.69%19.81M5,224.31%19.41M72.35%512.57K
Asset deal income ---------99.07%176.42K-99.50%95.2K376.01%95.2K--44.05K31,919.42%18.89M--18.89M--20K----
Other revenue 5.65%6.98M17.62%3.27M-12.05%14.19M10.66%11.19M-11.52%6.61M-28.15%2.78M38.87%16.14M23.93%10.12M42.37%7.47M142.49%3.87M
Operating profit 378.00%258.91M177.61%80.82M51.91%189.67M177.80%121.07M105.49%54.16M90.53%29.11M-2.70%124.85M-48.89%43.58M-56.33%26.36M-67.35%15.28M
Add:Non operating Income 64.87%385.28K-58.44%69.73K-54.11%554.64K-57.03%442.09K-46.03%233.69K-1.82%167.81K97.71%1.21M227.73%1.03M369.46%432.98K3.19%170.91K
Less:Non operating expense -64.24%2.33M-92.37%439.18K489.03%17.09M199.31%6.67M257.19%6.52M1,005.68%5.75M-9.12%2.9M162.49%2.23M352.51%1.83M398.20%520.3K
Total profit 436.73%256.96M241.94%80.45M40.57%173.13M170.97%114.85M91.77%47.88M57.59%23.53M-2.05%123.16M-49.98%42.38M-58.43%24.97M-68.13%14.93M
Less:Income tax cost 214.01%25.2M242.17%15.89M1,879.38%7.67M490.92%24.51M214.35%8.02M7,467.61%4.64M-97.71%387.71K-141.22%-6.27M-165.51%-7.02M-100.74%-63.01K
Net profit 481.58%231.77M241.88%64.56M34.77%165.45M85.68%90.34M24.60%39.85M25.96%18.89M12.83%122.77M-30.02%48.65M-35.18%31.98M-60.93%14.99M
Net profit from continuing operation 481.58%231.77M241.88%64.56M34.77%165.45M85.68%90.34M24.60%39.85M25.96%18.89M12.83%122.77M-30.02%48.65M-35.18%31.98M-60.93%14.99M
Less:Minority Profit 330.04%4.6M17.19%-1.76M139.72%2.52M69.76%-1.37M29.80%-2M-93.46%-2.13M3.71%-6.34M-20.88%-4.54M-37.20%-2.85M16.34%-1.1M
Net profit of parent company owners 442.77%227.16M215.65%66.33M26.20%162.94M72.41%91.71M20.15%41.85M30.57%21.01M11.89%129.11M-27.41%53.19M-32.25%34.83M-59.45%16.09M
Earning per share
Basic earning per share 430.00%1.06210.00%0.3124.59%0.7672.00%0.4325.00%0.225.00%0.11.67%0.61-37.50%0.25-46.67%0.16-68.00%0.08
Diluted earning per share 405.00%1.01200.00%0.324.59%0.7672.00%0.4325.00%0.225.00%0.11.67%0.61-37.50%0.25-46.67%0.16-68.00%0.08
Other composite income -24.62M
Other composite income of parent company owners -----------24.62M----------------------------
Total composite income 481.58%231.77M241.88%64.56M14.71%140.83M85.68%90.34M24.60%39.85M25.96%18.89M12.83%122.77M-30.02%48.65M-35.18%31.98M-60.93%14.99M
Total composite income of parent company owners 442.77%227.16M215.65%66.33M7.14%138.32M72.41%91.71M20.15%41.85M30.57%21.01M11.89%129.11M-27.41%53.19M-32.25%34.83M-59.45%16.09M
Total composite income of minority owners 330.04%4.6M17.19%-1.76M139.72%2.52M69.76%-1.37M29.80%-2M-93.46%-2.13M3.71%-6.34M-20.88%-4.54M-37.20%-2.85M16.34%-1.1M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Zhongtianyun Certified Public Accountants (Special General Partnership)------Zhongtianyun Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data